Literature DB >> 3783141

Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control.

P J Lustman, L S Griffith, R E Clouse, P E Cryer.   

Abstract

The lifetime prevalence of psychiatric illness was determined in 114 patients with diabetes mellitus (types I and II) who were selected randomly from patients undergoing diabetes evaluations at a large medical center. The relationship of psychiatric illness to diabetic control was studied using glycosylated hemoglobin (HbA1) and self-report measures of metabolic symptoms. Seventy-one percent of the patients had a lifetime history of at least one criteria-defined psychiatric illness; affective and anxiety disorders were the most common diagnoses. A significant difference (p = .02) in mean glycosylated hemoglobin levels was observed comparing patients with a recent psychiatric illness (mean = 10.8%) to those never psychiatrically ill (mean = 9.6%). These psychiatrically ill patients also reported more symptoms of poor metabolic control and more distress associated with these symptoms than did patients never psychiatrically ill (p less than .0001 for both). The overall report of diabetes symptoms was unrelated to HbA1 (p = .25) and was influenced primarily by the recent presence of psychiatric disorder (p less than .0001). We conclude that emotional illness is associated with both poorer metabolic control and the increased report of clinical symptoms of diabetes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783141     DOI: 10.1097/00005053-198612000-00005

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  25 in total

1.  High anxiety is associated with an increased risk of death in an older tri-ethnic population.

Authors:  Glenn V Ostir; James S Goodwin
Journal:  J Clin Epidemiol       Date:  2006-01-23       Impact factor: 6.437

2.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

4.  Effect of buspirone: An anxiolytic drug on blood glucose in humans.

Authors:  S K Ojha; M Nandave; C Sharma
Journal:  Indian J Clin Biochem       Date:  2006-09

5.  Assessing the association of depression and anxiety with symptom reporting among individuals with type 2 diabetes.

Authors:  Arielle G Asman; Claire J Hoogendoorn; M Diane McKee; Jeffrey S Gonzalez
Journal:  J Behav Med       Date:  2019-05-20

6.  On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type I diabetes.

Authors:  J Metsch; H Tillil; J Köbberling; G Sartory
Journal:  Int J Behav Med       Date:  1995

7.  Non-insulin-dependent diabetes mellitus and depression in a middle-aged Finnish population.

Authors:  U Rajala; S Keinänen-Kiukaanniemi; S L Kivelä
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-08       Impact factor: 4.328

8.  Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.

Authors:  Feng Li; Mian Zhang; Dan Xu; Can Liu; Ze-Yu Zhong; Ling-Ling Jia; Meng-Yue Hu; Yang Yang; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2014-06       Impact factor: 6.150

9.  The comorbidity of diabetes mellitus and depression.

Authors:  Wayne J Katon
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

10.  Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study.

Authors:  M Trento; M Trevisan; M Raballo; P Passera; L Charrier; F Cavallo; M Porta
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.